Search

everythinglearnresearchcommunity

for

Search:↓

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

Using existing drugs for new purposes can effectively treat infections resistant to multiple antibiotics.

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

ALA-photodynamic therapy helps reduce acne by causing acne cell death and lowering certain skin protein levels.

Nanocapsules can improve clobetasol delivery to hair follicles, reducing side effects.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Wedelolactone may help treat lung fibrosis by reducing inflammation and lung damage.

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

SIPHL1 from tomato enhances plants' response to low phosphate levels.

Decanoic acid may help treat PCOS by reducing androgen levels and improving glucose sensitivity.

A new peptide delivered through microneedles can effectively promote hair regrowth.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Liposomes and niosomes improve finasteride delivery for hair loss treatment.

Nanostructured lipid carriers can improve alopecia treatment by enhancing drug delivery and promoting hair growth.

MLPH helps hair grow by activating IGF-1 signaling in hair cells.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

A new compound, HTPI, promotes hair growth by protecting cells from damage and regulating energy use.

Procyanidins and phosphatidic acids help promote hair growth.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

Invasomes effectively deliver drugs through the skin and have potential for improved treatments.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

PDGF and its receptors are crucial for stem cell growth and function.